This analysis estimates the incidence and economic burden of antimicrobial resistant gonococcal infections in young adults, highlighting significant costs for women.
Using progressively refined methodology, this study estimated the number and cost of incident antimicrobial resistant gonococcal (AR GC) infections during 2018-2023. An estimated 787,000 incident AR GC infections in persons aged 15-39 years occurred in 2023, with lifetime costs of $214.5M and 80% of costs attributable to infections in women.
No takes yet. Share an insight, caveat, or question.
Kreisel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: